alpha-synuclein oligomer inhibitors (Treventis)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namealpha-synuclein oligomer inhibitors (Treventis)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSynuclein alpha inhibitors

TargetsSynuclein alpha

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTreventis Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTreventis Corp

Active IndicationsN/A

Inactive IndicationsParkinson Disease

ATC CodeN/A